Galmed Pharmaceuticals(GLMD) - 2020 Q3 - Earnings Call Transcript

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Q3 2020 Earnings Conference Call November 12, 2020 8:30 AM ET Company Participants Allen Baharaff - President & Chief Executive Officer Yohai Stenzler - Chief Financial Officer Dr. Liat Hayardeny - Chief Scientific Officer Conference Call Participants Steve Seedhouse - Raymond James Kristen Kluska - Cantor Fitzgerald Ed Arce - H.C. Wainwright Operator Good day, and welcome to the Galmed Conference Call to discuss financial results for the third quarter of 2020. Toda ...